Thirty-five days after neural induction with CHIR99021 and forskolin, most of the glioma was converted into Tuj1-positive (~90%) or MAP2-positive (~80%) cells showing morphological diversity (Fig 2A–2D). The gene discussed is MAP2; the disease is central nervous system cancer.